• Former Allergan exec heads to Revance as it challenges Botox; Mark Pruzanski surrounds himself with more teammates

    1 month ago - By San Diego Biotechnology

    David Hollander? Revance feels like it has a competitive advantage over AbbVie's blockbuster Botox with only biannual injections of its freshly approved Daxxify, as opposed injections every three or four months that Botox requires. But...
    Read more ...